-
Nepali climber alive after six days missing on Everest
-
South Korea's ruling party fails to flip Seoul in blemish to local polls showing
-
Brunson vows no let up after Knicks comeback sinks Spurs
-
From poplars to pistachios, Afghans rediscover the value of trees
-
South Korea edge El Salvador 1-0 in final World Cup warm-up
-
Wembanyama 'not worried' after Knicks stun Spurs in finals opener
-
Knicks rally to beat Spurs in NBA Finals game-one thriller
-
N. Korea's Kim vows 'exponential' boost in nuclear forces
-
Overtaken by Hong Kong in global wealth management, Swiss keep cool
-
Indonesian rupiah falls to record low against US dollar
-
Stocks drop on AI, rate hike worries as Lebanon deal hits oil
-
US House votes to curb Trump on Iran war as talks stall
-
'Our pool is bigger than skyscrapers': Amid war, Trump touts Washington projects
-
Ferrari tipped to end Antonelli's winning run
-
"I am from Bosnia" -- Bosnia's first World Cup success
-
Brumbies battle the odds in Super Rugby playoff against Hurricanes
-
Morocco's dual-national scouting policy pays rich dividends
-
Favourites keep apart in lead up to Tour de France
-
Ukraine strike kills 3 in Russian-occupied Crimea
-
Fiji rejects Australian billionaire's 'Pacific ashtray' plan to ship, burn waste
-
In Peru's highlands, hopelessness shapes a bitter presidential runoff
-
Tim Berners-Lee calls for AI to preserve 'original values' of web
-
China bans New Zealand lawmakers over Taiwan trip
-
South Korean adoptees sue Denmark over right to know birth families
-
Show must go on for ballerinas in crisis-hit Cuba
-
NBA 'on schedule' with Europe league plans: Silver
-
Plan to merge BBL's Melbourne teams sparks 'anxiety' for players
-
World Cup fans barred from bringing water bottles into stadia
-
Israel, Lebanon agree to conditional ceasefire
-
New Delhi hotel blaze kills 21, including foreigners
-
Bayeux Tapestry to be moved in secret to British Museum: minister
-
Meta lashes Australia's bid to make tech giants pay for news
-
NZ football star meets influencer behind viral fame
-
'Thank you, Football' - quarterback Russell Wilson confirms move to broadcasting
-
Meta lashes Australia bid to make tech giants pay for news
-
NASA ends mission after loss of Mars probe
-
SpaceX aims to raise record $75 bn in stock market debut
-
Algeria sucker-punch Netherlands in World Cup warm up
-
Iran FM says 'no tangible progress' in talks but Trump says deal close
-
DRC cheered on by 23,000 fans in World Cup warm-up
-
New York turns blue and orange as Knicks fever grips city
-
Javier Bardem terrifies Amy Adams in TV adaptation of 'Cape Fear'
-
Arnaldi into French Open semis as Berrettini retires injured
-
Cuba has 'technocrats' willing to negotiate, Rubio says
-
Authorities warn of World Cup ticket, merchandise scams
-
US sanctions interrupt Visa, Mastercard payments in Cuba
-
Cobolli sinks Auger-Aliassime to book French Open semi spot
-
Police probe alleged assault on coach of Australian tennis player in Birmingham
-
France's Saliba 'fine' after injury scare, says Deschamps
-
Somalia ex-PM says attacked by govt forces in Mogadishu
Trump announces departure of food and drug regulation chief
President Donald Trump said Tuesday his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency.
During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes.
"Marty is a terrific guy, but he's going to go on, and he's going to lead a good life," Trump said, speaking to journalists who pressed him on the reported resignation that comes after weeks of rumors that the president planned to fire his FDA commissioner.
Makary, a surgeon and former Fox News contributor, made waves during the Covid-19 pandemic as an outspoken critic of the medical establishment and the health measures of the time.
He took over the FDA promising reform. He leaves just over a year later, facing criticism from all angles, including from pharmaceutical executives, tobacco lobbyists, and anti-abortion activists.
Conservatives against the abortion pill mifepristone accuse Makary of taking too long to complete and issue a review of the drug that's been FDA-approved for 25 years, but which they continue to target.
The Trump administration meanwhile forged ahead with a policy allowing for the sale of flavored e-cigarettes despite resistance from Makary, who had voiced concern over the appeal of the vapes to youth.
Many pharmaceutical executives said Makary's initiatives to shake up the drug review process had only created more problems.
And public health leaders accused him of catering to anti-vaccine activists after the FDA put out an unsupported memo claiming deaths linked to the Covid-19 vaccine.
It's the latest in a string of shake-ups at the health department overseen by noted vaccine skeptic Robert F. Kennedy Jr, with figures seen as more conventional put forth as nominees to be surgeon general as well as helm the Centers for Disease Control and Prevention.
O.Schlaepfer--VB